Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases

Multiple Sclerosis

Volumn 22, Issue 14, 2016, Pages 1821-1829

  Baumann, Matthias ^a   Hennes, Eva Maria ^b   Schanda, Kathrin ^a   Karenfort, Michael ^c   Kornek, Barbara ^d   Seidl, Rainer ^d   Diepold, Katharina ^e   Lauffer, Heinz ^f   Marquardt, Iris ^g   Strautmanis, Jurgis ^h   Syrbe, Steffen ⁱ   Vieker, Silvia ^j   Höftberger, Romana ^d   Reindl, Markus ^a   Rostásy, Kevin ^k  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b OLGAHOSPITAL   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e Children's Hospital   (Germany)

^f UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^g UNIVERSITY OF OLDENBURG   (Germany)

^h CHILDREN'S CLINICAL UNIVERSITY HOSPITAL   (Latvia)

ⁱ UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^j INSTITUTE OF PATHOLOGY   (Germany)

^k UNIVERSITY OF WITTEN HERDECKE   (Germany)

more..

Author keywords

acquired demyelinating syndromes; acute disseminated encephalomyelitis; children; magnetic resonance imaging; Multiphasic disseminated encephalomyelitis; myelin oligodendrocyte glycoprotein

Indexed keywords

IMMUNOGLOBULIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; MOG PROTEIN, HUMAN;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BRAIN DISEASE; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; ENCEPHALITIS; FEMALE; HUMAN; MALE; MULTIPHASIC DISSEMINATED ENCEPHALOMYELITIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; BLOOD; CEREBROSPINAL FLUID; DEMYELINATING DISEASE; DIAGNOSTIC IMAGING; ENCEPHALOMYELITIS; FOLLOW UP; IMMUNOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DEMYELINATING AUTOIMMUNE DISEASES, CNS; ENCEPHALOMYELITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN;

EID: 85005932169     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458516631038     Document Type: Article

References (25)

1. Krupp LB, Tardieu M, Amato MP, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: Revisions to the 2007 definitions. Mult Scler 2013; 19: 1261-1267.
2. Di Pauli F, Mader S, Rostásy K, et al. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin Immunol 2011; 138: 247-254.
3. Pröbstel AK, Dornmair K, Bittner R, et al. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 2011; 77: 580-588.
4. Baumann M, Sahin K, Lechner C, et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry 2015; 86: 265-272.
5. Huppke P, Rostásy K, Karenfort M, et al. Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler 2013; 19: 941-946.
6. Ketelslegers IA, Van Pelt DE, Bryde S, et al. Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort. Mult Scler 2015; 21: 1513-1520.
7. Rostásy K, Mader S, Hennes EM, et al. Persisting myelin oligodendrocyte glycoprotein antibodies inaquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler 2013; 19: 1052-1059.
8. Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 2014; 82: 474-481.
9. Fernandez-Carbonell C, Vargas-Lowy D, Musallam A, et al. Clinical and MRI phenotype of children with MOG antibodies. Mult Scler 2016; 22: 174-184.
10. Rostásy K, Mader S, Schanda K, et al. Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. Arch Neurol 2012; 69: 752-756.
11. Hino-Fukuyo N, Haginoya K, Nakashima I, et al. Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies. Brain Dev 2015; 37: 849-852.
12. Kariyawasam S, Singh RR, Gadian J, et al. Clinical and radiological features of recurrent demyelination following acute disseminated encephalomyelitis (ADEM). Mult Scler Relat Disord 2015; 4: 451-456.
13. Ching BH, Mohamed AR, Khoo TB, et al. Multiphasic disseminated encephalomyelitis followed by optic neuritis in a child with gluten sensitivity. Mult Scler 2015; 21: 1209-1211.
14. Lechner C, Baumann M, Hennes EM, et al. Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease. J Neurol Neurosurg Psychiatry. Epub ahead of print 8 2015. DOI: 10.1136/jnnp-2015-311743.
15. Mader S, Gredler V, Schanda K, et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 2011; 8: 184.
16. Hacohen Y, Absoud M, Deiva K, et al. Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children. Neurol Neuroimmunol Neuroinflamm 2015; 2: e81.
17. Mayer MC, Breithaupt C, Reindl M, et al. Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases. J Immunol 2013; 191: 3594-3604.
18. Dale RC, Tantsis EM, Merheb V, et al. Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton. Neurol Neuroimmunol Neuroinflamm 2014; 1: e12.
19. Saadoun S, Waters P, Owens GP, et al. Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain. Acta Neuropathol Commun 2014; 2: 35.
20. Spadaro M, Gerdes LA, Mayer MC, et al. Histopathology and clinical course of MOG-antibody-associated encephalomyelitis. Ann Clin Transl Neurol 2015; 2: 295-301.
21. König FB, Wildemann B, Nessler S, et al. Persistence of immunopathological and radiological traits in multiple sclerosis. Arch Neurol 2008; 65: 1527-1532.
22. Di Pauli F, Höftberger R, Reindl M, et al. Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology. Neurol Neuroimmunol Neuroinflamm 2015; 2: e175.
23. Absoud M, Lim MJ, Appleton R, et al. Paediatric neuromyelitis optica: Clinical, MRI of the brain and prognostic features. J Neurol Neurosurg Psychiatry 2015; 86: 470-472.
24. Krupp LB, Banwell B, Tenembaum S,. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007; 68: S7-S12.
25. Koelman DL, Mateen FJ,. Acute disseminated encephalomyelitis: Current controversies in diagnosis and outcome. J Neurol 2015; 262: 2013-2024.